Small neuroendocrine pancreatic tumors in multiple endocrine neoplasia type 1 (MEN1): Least significant change of tumor diameter as determined by endoscopic ultrasound (EUS) imaging

Experimental and Clinical Endocrinology and Diabetes

Volumn 114, Issue 7, 2006, Pages 361-365

  Kann, Peter Herbert ^a,c,d   Kann, B ^a   Fassbender, W J ^b   Forst, T ^c   Bartsch, D K ^a   Langer, P ^a  

^a Fachbereich Medizin der Universitat Marburg   (Germany)

^b Holy Ghost Academic Hospital   (Germany)

^c Institute for Clinical Research and Development   (Germany)

^d PHILIPPS UNIVERSITY MARBURG   (Germany)

Author keywords

Coefficient of variation; Endocrine; Endoscopical ultrasound; Endosonography; EUS; Least significant change; MEN1; Multiple endocrine neoplasia; Neuroendocrine; Pancreas; PET; RECIST; Reproducibility; Tumor

Indexed keywords

ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; ENDOSCOPIC ECHOGRAPHY; FOLLOW UP; HUMAN; MULTIPLE ENDOCRINE NEOPLASIA; PANCREAS TUMOR; PRIORITY JOURNAL; PROGNOSIS; TUMOR VOLUME;

CARCINOMA, NEUROENDOCRINE; HUMANS; MULTIPLE ENDOCRINE NEOPLASIA TYPE 1; PANCREATIC NEOPLASMS; POSITRON-EMISSION TOMOGRAPHY; PROSPECTIVE STUDIES; REPRODUCIBILITY OF RESULTS;

EID: 33746191153     PISSN: 09477349     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2006-924322     Document Type: Article

References (35)

1. Bartsch DK, Langer P, Wild A, Schilling T, Celik I, Rothmund M, Nies C. Pancreaticoduodenal endocrine tumors in multiple endocrine neoplasia type 1: surgery or surveillance? Surgery 2000; 128: 958-966
2. Byrne MJ, Nowak AK. Modified RECIST criteria for assessment of response in malignant pleural mesothelioma. Ann Oncol 2004; 15: 257-260
3. Carty SE, Helm AK, Amico JA, Clarke MR, Foley TP, Watson CG, Mulvihill JJ. The variable penetrance and spectrum of manifestations of multiple endocrine neoplasia type 1. Surgery 1998; 124: 1106-1113
4. Chanson P, Cadiot G, Murat A. Management of patients and subjects at risk for multiple endocrine neoplasia type 1: MEN 1. Horm Res 1997; 47: 211-220
5. Cortes J, Rodriguez J, Diaz-Gonzalez JA, Garzon C, Gurpide A, Arbea L, Gil-Bazo I, Navarro V, Cambeiro M, Nicolas AI, Martin-Algarra S, Garcia-Foncillas J, Calvo E. Comparison of unidimensional and bidimensional measurements in metastatic non-small cell lung cancer. Br J Cancer 2002; 87: 158-160
6. Dancygier H. Endoscopic ultrasonography in chronic pancreatitis. Gastrointest Endosc Clin N Am 1995; 5: 1052-1057
7. Devière J, Finet L, Dunham F, Cremer M. Endoscopic ultrasonography in chronic pancreatitis. Endoscopy 1994; 26: 808-809
8. Gauger PG, Scheiman JM, Wamsteker EJ, Richards ML, Doherty GM, Thompson NW. Role of endoscopic ultrasonography in screening and treatment of pancreatic endocrine tumours in asymptomatic patients with multiple endocrine neoplasia type 1. Br J Surg 2003; 90: 748-754
9. Grimm H, Mayendo A, Soehendra N. Endoluminal ultrasound for the diagnosis and staging of pancreatic cancer. Baillieres Clin Gastroenterol 1990; 4: 869-888
10. James K, Eisenhauer E, Christian M, Terenziani M, Vena D, Muldal A, Therasse P. Measuring response in solid tumors: unidimensional versus bidimensional measurement. J Natl Cancer Inst 1999; 91: 523-528
11. Kann P, Bittinger F, Engelbach M, Bohner S, Weis A, Beyer J. Endosonography of insulin-secreting and clinically non-functioning neuroendocrine tumors of the pancreas: criteria for benignancy and malignancy. Eur J Med Res 2001; 6: 385-390
12. Kann PH, Wirkus B, Keth A, Goitom K. Pitfalls in endosonographic imaging of suspected insulinomas: pancreatic nodules of unknown dignity. Eur J Endocrinol 2003; 148: 531-534
13. Kann PH, Wirkus B, Behr T, Klose K-J, Meyer S. Endosonographic imaging of benign and malignant pheochromocytomas. J Clin Endocrinol Metab 2004; 89: 1694-1697
14. Kann PH. Endosonographic imaging of the adrenals. Endoscopy 2005; 37: 244-253
15. Langer P, Kann PH, Fendrich V, Richter G, Diehl S, Rothmund M, Bartsch DK. Prospective evaluation of imaging procedures for the detection of pancreaticoduodenal endocrine tumors (PETs) in patients with multiple endocrine neoplasia type 1 (MEN1). World J Surg 2004; 28: 1317-1322
16. Lees WR. Endoscopic ultrasonography of chronic pancreatitis and pancreatic pseudocysts. Scand J Gastroenterol Suppl 1986; 123: 123-129
17. Mazumdar M, Smith A, Schwartz LH. A statistical simulation study finds discordance between WHO criteria and RECIST guideline. J Clin Epidemiol 2004; 57: 358-365
18. McHugh K, Kao S. Response evaluation criteria in solid tumours (RECIST): problems and need for modifications in paediatric oncology? Br J Radiol 2003; 76: 433-436
19. Miller AB, Hoogstraten B, Staquet M, Winkler A. Reporting results of cancer treatment. Cancer 1981; 47: 207-214
20. Müller MF, Meyerberger C, Bertschinger P, Schaer R, Marincek B. Pancreatic tumors: Evaluation with endoscopic US, CT, and MR imaging. Radiology 1994; 190: 745-751
21. Nattermann C, Dancygier H. Endosonographie bei Tumoren des Pankreas und der Gallenwege. Leber Magen Darm 1993; 1: 13-23
22. Nattermann C, Goldschmidt AJW, Dancygier H. Endosonography in chronic pancreatitis - a comparison between endoscopic retrograde pancreatography and endoscopic ultrasonography. Endoscopy 1993; 25: 565-570
23. Nattermann C, Goldschmidt AJW, Dancygier H. Endosonographie in der Dignitätsbeurteilung von Pankreastumoren. Dtsch Med Wochenschr 1995; 120: 1571-1576
24. Owen NJ, Sohaib SA, Peppercorn PD, Monson JP, Grossman AB, Besser GM, Reznek RH. MRI of pancreatic neuroendocrine tumours. Br J Radiol 2001; 74: 968-973
25. Padhani AR, Ollivier L. The RECIST (Response Evaluation Criteria in Solid Tumors) criteria: implications for diagnostic radiologists. Br J Radiol 2001; 74: 983-986
26. Park JO, Lee SI, Song SY, Kim K, Kim WS, Jung CW, Park YS, Im YH, Kang WK, Lee MH, Lee KS, Park K. Measuring response in solid tumors: comparison of RECIST and WHO response criteria. Jpn J Clin Oncol 2003; 33: 533-537
27. Rösch T, Lorenz R, Braig C, Feuerbach S, Siewert JR, Classen M. Endosonographische Diagnostik bei Pankreastumoren. Dtsch Med Wochenschr 1990; 115: 1339-1347
28. Therasse P, Arbuck SG, Eisenhauer EA, Wanders J, Kaplan RS, Rubinstein L, Verweij J, Van Glabbeke M, van Oosterom AT, Christian MC, Gwyther SG. New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada. J Natl Cancer Inst 2000; 92: 205-216
29. Trillet-Lenoir V, Freyer G, Kaemmerlen P, Fond A, Pellet O, Lombard-Bohas C, Gaudin JL, Lledo G, Mackiewicz R, Gouttebel MC, Moindrot H, Boyer JD, Chassignol L, Stremsdoerfer N, Desseigne F, Moreau JM, Hedelius F, Moraillon A, Chapuis F, Bleuse JP, Barbier Y, Heilmann MO, Valette PJ. Assessment of tumour response to chemotherapy for metastatic colorectal cancer: accuracy of the RECIST criteria. Br J Radiol 2002; 75: 903-908
30. van Klaveren RJ, Aerts JG, de Bruin H, Giaccone G, Manegold C, van Meerbeeck JP. Inadequacy of the RECIST criteria for response evaluation in patients with malignant pleural mesothelioma. Lung Cancer 2004; 43: 63-69
31. Watanabe H, Yamamoto S, Kunitoh H, Sekine I, Yamamoto N, Ohe Y, Tamura T, Kodama T, Sugimura K, Saijo N. Tumor response to chemotherapy: the validity and reproducibility of RECIST guidelines in NSCLC patients. Cancer Sci 2003; 94: 1015-1020
32. Wiersema MJ, Hawes H, Lehmann GA, Kochmann ML, Sherman S, Kopecky KK. Prospective evaluation of endoscopic ultrasonography and endoscopic retrograde cholangiopancreatography in patients with chronic abdominal pain of suspected pancreatic origin. Endoscopy 1993; 25: 555-564
33. Wiersema MJ, Wiersema LM. Endosonography of the pancreas: normal variation versus changes of early chronic pancreatitis. Gastrointest Endosc Clin N Am 1995; 5: 487-496
34. Yasuda K, Mukai H, Fujimoto S, Nakajiama M, Kawai K. The diagnosis of pancreatic cancer by endoscopic ultrasonography. Gastrointest Endosc 1988; 134: 1-8
35. Zuccaro G Jr, Sivak MV Jr. Endoscopic ultrasonography in the diagnosis of chronic pancreatitis. Endoscopy 1992; 24: 347-349